ITCC-065 IBRUTINIB
Ibrutinib randomized safety and efficacy study in pediatric patients with mature B-cell NHL, including Burkitt lymphoma/Leukemia and Diffuse Large B-cell Lymphoma
Promotor Name : JANSSEN
Investigator Name : A. BURKE
Trial registered on clinicaltrial.gov: NCT02703272
